Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect

Human Mutation

Volumn 31, Issue 8, 2010, Pages

  Sommer, Wolfgang H ^a,b   Lidström, Jessica ^a,d   Sun, Hui ^a   Passer, Derek ^a   Eskay, Robert ^a   Parker, Stephen C J ^a   Witt, Stephanie H ^b   Zimmermann, Ulrich S ^b,e   Nieratschker, Vanessa ^b   Rietschel, Marcella ^b   Margulies, Elliott H ^a   Palkovits, Miklós ^c   Laucht, Manfred ^b   Heilig, Markus ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Brain; Gene expression; NPY; Promoter variant; Stress coping

Indexed keywords

MESSENGER RNA; NUCLEAR FACTOR Y; DNA; NEUROPEPTIDE Y; PROTEIN BINDING;

ANXIETY; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CINGULATE GYRUS; COMPUTER MODEL; CONTROLLED STUDY; DEPRESSION; DNA STRUCTURE; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE INTERACTION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RADIOIMMUNOASSAY; SINGLE NUCLEOTIDE POLYMORPHISM; CHEMISTRY; ENVIRONMENT; GENETICS; METABOLISM; PREFRONTAL CORTEX; REGRESSION ANALYSIS;

DNA; ENVIRONMENT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; NEUROPEPTIDE Y; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REGRESSION ANALYSIS;

ANIMALIA;

EID: 77955061308     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21299     Document Type: Article

References (61)

1. American Psychiatric Association (1994b) Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
2. Balasubramanian B, Pogozelski WK, Tullius TD (1998) DNA strand breaking by the hydroxyl radical is governed by the accessible surface areas of the hydrogen atoms of the DNA backbone. Proc Natl Acad Sci U S A 95:9738-9743. (Pubitemid 28415239)
3. Barr CS, Dvoskin RL, Gupte M, Sommer W, Sun H, Schwandt ML, Lindell SG, Kasckow JW, Suomi SJ, Goldman D, Higley JD, Heilig M (2009) Functional CRH variation increases stress-induced alcohol consumption in primates. Proc Natl Acad Sci U S A 106:14593-14598.
4. Beck AT, Steer RA (1987) Beck Depression Inventory (BDI). San Antonio: The Psychological Corporation Inc.
5. Björk K, Rimondini R, Hansson AC, Terasmaa A, Hyytia P, Heilig M, Sommer WH (2008) Modulation of voluntary ethanol consumption by beta-arrestin 2. FASEB J 22:2552-2560. (Pubitemid 351948672)
6. Blomeyer D, Treutlein J, Esser G, Schmidt MH, Schumann G, Laucht M (2008) Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biol Psychiatry 63:146-151. (Pubitemid 350299326)
7. Buckland PR, Hoogendoorn B, Coleman SL, Guy CA, Smith SK, O'Donovan MC (2005) Strong bias in the location of functional promoter polymorphisms. Hum Mutat 26:214-223. (Pubitemid 41254377)
8. Buckland PR, Hoogendoorn B, Guy CA, Coleman SL, Smith SK, Buxbaum JD, Haroutunian V, O'Donovan MC (2004) A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity. Biochim Biophys Acta 1690:238-249.
9. Caberlotto L, Hurd YL (1999) Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport 10:1747-1750. (Pubitemid 29354304)
10. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942. (Pubitemid 40916416)
11. Chiodera P, Volpi R, Pilla S, Cataldo S, Coiro V (2000) Decline in circulating neuropeptide Y levels in normal elderly human subjects. Eur J Endocrinol 143:715-716.
12. Cotton CH, Flint J, Campbell TG (2009) Is there an association between NPY and neuroticism? Nature 458:E6.
13. Czermak C, Hauger R, Drevets WC, Luckenbaugh DA, Geraci M, Charney DS, Neumeister A (2008) Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression. J Affect Disord 110:277-281.
14. Drevets WC, Savitz J, Trimble M (2008) The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 13:663-681.
15. Du L, Faludi G, Palkovits M, Demeter E, Bakish D, Lapierre YD, Sotonyi P, Hrdina PD (1999) Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol Psychiatry 46:196-201. (Pubitemid 29320071)
16. Duan S, Gao R, Xing Q, Du J, Liu Z, Chen Q, Wang H, Feng G, He L (2005) A family-based association study of schizophrenia with polymorphisms at three candidate genes. Neurosci Lett 379:32-36. (Pubitemid 40462393)
17. Dwivedi Y, Mondal AC, Rizavi HS, Faludi G, Palkovits M, Sarosi A, Conley RR, Pandey GN (2006) Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims. Arch Gen Psychiatry 63:639-648.
18. Enoch MA, Shen PH, Xu K, Hodgkinson C, Goldman D (2006) Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol 20:19-26. (Pubitemid 44576654)
19. Freudenberg J, Fu YH, Ptacek LJ (2007) Enrichment of HapMap recombination hotspot predictions around human nervous system genes: evidence for positive selection? Eur J Hum Genet 15:1071-1078.
20. Greenbaum JA, Pang B, Tullius TD (2007) Construction of a genome-scale structural map at single-nucleotide resolution. Genome Res 17:947-953. (Pubitemid 46919729)
21. Hall H, Lawyer G, Sillen A, Jonsson EG, Agartz I, Terenius L, Arnborg S (2007) Potential genetic variants in schizophrenia: a Bayesian analysis. World J Biol Psychiatry 8:12-22. (Pubitemid 46291197)
22. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Bjork K, Soverchia L, Terasmaa A, Massi M, Heilig M, Ciccocioppo R (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A 103:15236-15241.
23. Hashimoto T, Arion D, Unger T, Maldonado-Aviles JG, Morris HM, Volk DW, Mirnics K, Lewis DA (2007) Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry.
24. Hattiangady B, Rao MS, Shetty GA, Shetty AK (2005) Brain-derived neurotrophic factor, phosphorylated cyclic AMP response element binding protein and neuropeptide Y decline as early as middle age in the dentate gyrus and CA1 and CA3 subfields of the hippocampus. Exp Neurol 195:353-371. (Pubitemid 41297788)
25. Hautzinger M, Bailer M, Worall H, Keller F (1994) Beck-Depressions- Inventar (BDI). Bern: Huber.
26. Heilig M (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38:213-224.
27. Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S, Sjogren M, Asberg M, Ekman R, Wahlestedt C, Agren H (2004) Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res 38:113-121.
28. Hettema JM, Neale MC, Myers JM, Prescott CA, Kendler KS (2006) A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry 163:857-864.
29. Higuchi H, Yang HY, Costa E (1988) Age-related bidirectional changes in neuropeptide Y peptides in rat adrenal glands, brain, and blood. J Neurochem 50:1879-1886.
30. Hokfelt T, Broberger C, Zhang X, Diez M, Kopp J, Xu Z, Landry M, Bao L, Schalling M, Koistinaho J, DeArmond SJ, Prusiner S, Gong J, Walsh JH (1998) Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Res Brain Res Rev 26:154-166.
31. Hou C, Jia F, Liu Y, Li L (2006) CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder. Brain Res 1095:154-158.
32. Inoue Y, Shinkai T, Utsunomiya K, Sakata S, Fukunaka Y, Yamaguchi W, Yamada K, Chen HI, Hwang R, Ohmori O, Nakamura J (2009) No association between a functional polymorphism in the promoter region of the neuropeptide Y gene (-485C>T) and schizophrenia. Neurosci Lett 452:72-74.
33. Itokawa M, Arai M, Kato S, Ogata Y, Furukawa A, Haga S, Ujike H, Sora I, Ikeda K, Yoshikawa T (2003) Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci Lett 347:202-204.
34. Joshi R, Passner JM, Rohs R, Jain R, Sosinsky A, Crickmore MA, Jacob V, Aggarwal AK, Honig B, Mann RS (2007) Functional specificity of a Hox protein mediated by the recognition of minor groove structure. Cell 131:530-543.
35. Kimberly A, Yonkers MD, Samson J (2000) Mood disorders measures. In: Handbook of psychiatric measures (Rush AJ, First MB, Blacker D, eds), pp 515-548. Washington, DC: American Psychiatric Association.
36. Lander ES (1996) The new genomics: global views of biology. Science 274:536-539.
37. Laucht M, Esser G, Baving L, Gerhold M, Hoesch I, Ihle W, Steigleider P, Stock B, Stoehr RM, Weindrich D, Schmidt MH (2000) Behavioral sequelae of perinatal insults and early family adversity at 8 years of age. J Am Acad Child Adolesc Psychiatry 39:1229-1237.
38. Laucht M, Esser G, Schmidt MH (1997) Developmental outcome of infants born with biological and psychosocial risks. Journal of Child Psychology and Psychiatry 38:843-853.
39. Laux L, Glanzmann P, Schaffner P, Spielberger CD (1981) The State-Trait Inventory. Göttingen: Hogrefe.
40. Lindberg C, Koefoed P, Hansen ES, Bolwig TG, Rehfeld JF, Mellerup E, Jorgensen OS, Kessing LV, Werge T, Haugbol S, Wang AG, Woldbye DP (2006) No association between the -399 C > T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population. Acta Psychiatr Scand 113:54-58.
41. Meyer-Lindenberg A, Weinberger DR (2006) Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7:818-827. (Pubitemid 44435264)
42. Mottagui-Tabar S, Prince JA, Wahlestedt C, Zhu G, Goldman D, Heilig M (2005) A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence. Alcohol Clin Exp Res 29:702-707. (Pubitemid 40686538)
43. Nikisch G, Mathé AA (2008) CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy. Eur Psychiatry 23:356-359.
44. Ordway GA, Stockmeier CA, Meltzer HY, Overholser JC, Jaconetta S, Widdowson PS (1995) Neuropeptide Y in frontal cortex is not altered in major depression. J Neurochem 65:1646-1650.
45. Parker SC, Hansen L, Abaan HO, Tullius TD, Margulies EH (2009) Local DNA topography correlates with functional noncoding regions of the human genome. Science 324:389-392.
46. Rogers R (2001) Handbook of diagnostic and structured interviewing. New York: Guilford.
47. Rutter M, Quinton D (1977) Psychiatric disorder - ecological factors and concepts of causation. In: Ecological factors in human development (McGurk M, ed), pp 173-187. Amsterdam: North Holland.
48. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7:3.
49. Shah SH, et al. (2009) Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet 5:e1000318.
50. Sommer W, Hyytia P, Kiianmaa K (2006) The alcohol-preferring AA and alcohol-avoiding ANA rats: neurobiology of the regulation of alcohol drinking. Addict Biol 11:289-309. (Pubitemid 46696912)
51. Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual for the State-Trait Anxiety Inventory. Paolo Alto, CA: Consulting Psychologists Press.
52. Spielberger CD, Reheiser E (2004) Measuring anxiety, anger, depression, and curiosity as emotional states and personality traits with the STAI, STAXI, and STPI. In: Comprehensive handbook of psychological assessment, vol.2: personality assessment (Hilsenroth MJ, Segal DL, eds), pp 70-86. New York: Wiley.
53. Thorsell A (2008) Central neuropeptide Y in anxiety- and stress-related behavior and in ethanol intake. Ann N Y Acad Sci 1148:136-140.
54. Uher R, McGuffin P (2008) The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 13:131-146.
55. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034.
56. Vela J, Gutierrez A, Vitorica J, Ruano D (2003) Rat hippocampal GABAergic molecular markers are differentially affected by ageing. J Neurochem 85:368-377. (Pubitemid 36438332)
57. Widdowson PS, Ordway GA, Halaris AE (1992) Reduced neuropeptide Y concentrations in suicide brain. J Neurochem 59:73-80.
58. Wittchen HU, Zaudig M, Fydrich T (1997) [Structured clinical interview for DSM-IV Axis I and II - SCID]. Hogrefe: Göttingen.
59. Yehuda R, Brand S, Yang RK (2006) Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol Psychiatry 59:660-663. (Pubitemid 43357961)
60. Zhou Z, et al. (2008) Genetic variation in human NPY expression affects stress response and emotion. Nature 452:997-1001.
61. Zill P, Preuss UW, Koller G, Bondy B, Soyka M (2008) Analysis of single nucleotide polymorphisms and haplotypes in the neuropeptide Y gene: no evidence for association with alcoholism in a German population sample. Alcohol Clin Exp Res 32:430-434. (Pubitemid 351300986)